Matches in Nanopublications for { ?s ?p "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP105938.RATik4X-quTDgHuiulnBbJFJDWsueNtzP1YUbXf5Tj0r8130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105938.RATik4X-quTDgHuiulnBbJFJDWsueNtzP1YUbXf5Tj0r8130_provenance.
- NP106525.RAc2H8WIqqas2Uad_s2L1yNTCXsndTEdIY3n0dCCoVkUk130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106525.RAc2H8WIqqas2Uad_s2L1yNTCXsndTEdIY3n0dCCoVkUk130_provenance.
- NP169156.RAYH5x4xO5Kre-aRA_Bj0VHFMm6ECAoZqRnnNUwxuEV8U130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169156.RAYH5x4xO5Kre-aRA_Bj0VHFMm6ECAoZqRnnNUwxuEV8U130_provenance.
- assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP203510.RAfEQhrWPAcizkRRs4qSbW-Ft8crVhxphOGeTi_I-3Hq8130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203510.RAfEQhrWPAcizkRRs4qSbW-Ft8crVhxphOGeTi_I-3Hq8130_provenance.
- NP203509.RArZFuavFQFM9uBhdP-J-ZAZvg5a86J5ixgoRYO9yeIBY130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203509.RArZFuavFQFM9uBhdP-J-ZAZvg5a86J5ixgoRYO9yeIBY130_provenance.
- NP169741.RAKgsTRdDWTlOclHoRhG0raa0LZIlgHm-UdNP0AORFtrg130_assertion description "[MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169741.RAKgsTRdDWTlOclHoRhG0raa0LZIlgHm-UdNP0AORFtrg130_provenance.